Pelvic inflammatory disease: Clinical sciences

1,650views

test

00:00 / 00:00

Pelvic inflammatory disease: Clinical sciences

Pediatrics

Pediatrics

Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Adnexal torsion: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Cholecystitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intussusception: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Sickle cell disease: Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Immune thrombocytopenia: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Sepsis (pediatrics): Clinical sciences
Celiac disease: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Congestive heart failure: Clinical sciences
COVID-19: Clinical sciences
Croup and epiglottitis: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Influenza: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Lyme disease: Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Toxic shock syndrome: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to hepatic masses: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to a suspected bone tumor (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Approach to recreational substance exposure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Pyloric stenosis: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Burns: Clinical sciences
Neurogenic shock: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to short stature: Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Adrenal insufficiency: Pathology review
Central nervous system infections: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Diabetes mellitus: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Obstructive lung diseases: Pathology review
Pneumonia: Pathology review
Psychiatric emergencies: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Autosomal trisomies: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
HIV and AIDS: Pathology review
Miscellaneous genetic disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Developmental and learning disorders: Pathology review
Eating disorders: Pathology review
Mood disorders: Pathology review
Breastfeeding
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Evaluaciones

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Preguntas

Preguntas del estilo USMLE® Step 2

0 de 4 completadas

A 26-year-old woman presents to the emergency department for evaluation of pelvic pain. She has also had vaginal discharge and nausea and vomiting for the past 3 days. The patient has multiple sexual partners and uses barrier protection inconsistently. Temperature is 39°C (102.2°F), blood pressure is 130/60 mmHg, pulse is 90/min, respiratory rate is 16/min, and oxygen saturation is 98% on room air. Pelvic examination demonstrates cervical motion tenderness, bilateral adnexal tenderness, and a mucopurulent cervical discharge. Labs including wet mount and nucleic amplification testing for gonorrhea and chlamydia are pending. Urine beta HCG is negative. Transvaginal ultrasonography shows no abnormalities. Which of the following is the best next step in management?  

Transcripción

Ver video solo

Pelvic inflammatory disease, or PID for short, is an inflammatory condition that can affect the uterus, fallopian tubes, ovaries, and peritoneum. PID is often caused by infection with sexually transmitted organisms such as gonorrhea and chlamydia. However, it may also be caused by microorganisms normally found in the vaginal flora.

Inflammation of the fallopian tubes, also known as salpingitis, increases the risk of infertility and ectopic pregnancy, while peritonitis can lead to pelvic adhesions and chronic pelvic pain. Even very mild cases of PID can lead to these sequelae. Finally, based on the severity, the clinical presentation of PID can range from asymptomatic or only mild symptoms to severe pelvic pain or even sepsis.

Your first step in evaluating a patient presenting with a chief concern suggesting PID is to perform a CABCDE assessment in order to determine if they are stable or unstable, which in most cases would indicate they’ve developed sepsis.

If the patient is unstable, stabilize their airway, breathing, and circulation right away. This means that you might have to intubate the patient, obtain IV access and continuously monitor their vital signs. In addition, you should immediately obtain an HCG pregnancy test!

Once you have initiated acute management, your next step is to take a focused history and physical exam. Patients typically report fever, nausea and vomiting, lower abdominal and pelvic pain, abnormal vaginal discharge, and intermenstrual or post-coital spotting.

Here’s a high-yield fact! If this patient reports upper abdominal pain, you should consider perihepatitis, also known as Fitz-Hugh-Curtis syndrome. Perihepatitis develops when the pathogenic microorganisms causing PID spill from the fimbriae and settle in the space surrounding the liver and diaphragm. This leads to inflammation of the liver capsule, without involvement of the liver parenchyma, as well as to the formation of the so-called “violin string” adhesions between the liver and the peritoneum, resulting in right upper quadrant pain that can mimic gallbladder disease.

Okay, back to the physical exam. Here, you might find signs of sepsis, such as elevated temperature, hypotension, and tachycardia. Be sure to assess the abdomen for diffuse tenderness, which may include rebound pain or guarding. In addition, the pelvic exam may reveal signs of cervicitis, such as swelling, inflammation, and mucopurulent cervical discharge, as well as cervical motion tenderness, uterine and adnexal tenderness. Finally, you might find an adnexal mass, which should get you to think about a tubo-ovarian abscess.

Based on these findings, you should suspect PID with sepsis. If this is the case, initiate IV fluids and targeted IV antibiotics. In addition, obtain appropriate labs, including CBC, chemistries, and lactate to monitor your patient’s progression, as well as blood cultures and nucleic acid amplification testing, or NAAT, to identify the causative infections. Lastly, obtain a gynecologic surgery consultation for possible exploration.

Alright, now that unstable patients are taken care of, let’s talk about stable patients. Your first step in managing a stable patient is a focused history and physical exam as well as labs including microscopy of the vaginal discharge, an ESR, CRP, and a NAAT for gonorrhea and chlamydia.

Here’s another high-yield fact! Although many cases of PID are associated with gonorrhea and chlamydia, other organisms such as Trichomonas vaginalis, bacterial vaginosis, Mycoplasma genitalium, cytomegalovirus, and bacteria that comprise the normal vaginal flora can be involved. So, consider also obtaining a NAAT for these organisms.

Alright, the history might reveal systemic symptoms of fever, nausea, and vomiting. Additionally, as stated earlier, the patient may report lower abdominal and pelvic pain, dysuria, dyspareunia, abnormal vaginal discharge, and intermenstrual or post-coital spotting.

When obtaining the history, be sure to discuss sexual activity, particularly recent sexual activity or new partners, as well as douching. A private, confidential discussion is important for all patients, including young patients like adolescents. Although it may be difficult, you should ask caregivers of young patients to step out of the room for this discussion.

Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Finally, review the patient's contraceptive history. Keep in mind that non-barrier methods of pregnancy prevention, such as oral contraceptive pills, do not prevent transmission of diseases such as gonorrhea or chlamydia.

Here is a high-yield fact! The presence of an intrauterine device, or IUD does not increase the risk of developing PID except within the first 3 weeks of insertion. Also, keep in mind that IUDs typically do not need to be removed while treating PID, unless treatment fails after 48 to 72 hours.

Fuentes

  1. "Sexually transmitted infections treatment guidelines, 2021" MMWR Recomm Rep (2021)
  2. "Pelvic Inflammatory Disease" Obstet Gynecol (2010)